Esuprone
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| Preferred IUPAC name
3,4-Dimethyl-2-oxo-2H-1-benzopyran-7-yl ethanesulfonate | |
| Identifiers | |
| |
3D model (JSmol)
|
|
| ChEMBL |
|
| ChemSpider |
|
PubChem CID
|
|
| UNII |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties[1] | |
| C13H14O5S | |
| Molar mass | 282.31 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Chemical compound
Esuprone is an experimental drug candidate being investigated as an antidepressant.[2] It acts as a monoamine oxidase A (MAO-A) inhibitor.[3]
References
[edit ]- ^ Ganellin, C. R (1996). Dictionary of pharmacological agents. CRC Press. p. 1056. ISBN 978-0-412-46630-4.
- ^ Vértes, Attila (2003). Handbook of nuclear chemistry. Springer. p. 155. ISBN 978-1-4020-1316-4.
- ^ Bergström, M; Westerberg, G; Németh, G; Traut, M; Gross, G; Greger, G; Müller-Peltzer, H; Safer, A; et al. (1997). "MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography". European Journal of Clinical Pharmacology. 52 (2): 121–8. doi:10.1007/s002280050260. PMID 9174681. S2CID 25359613.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Esuprone&oldid=1124560712"